Differences in strength expression on product labels of compounders and conventional manufacturers may lead to dosing errors.

US Food and Drug Administration; FDA.

Confusing labeling can affect safe medication preparation and administration. This safety announcement reviews case reports associated with inconsistent drug strength information that contributed to dosing errors of compounded injectable products.

Free full text

Related Resources

Web Resource

Government Resource

Medication errors resulting from confusion between risperidone (Risperdal) and ropinirole (Requip).

Food and Drug Administration; FDA.

Web Resource

Government Resource

Letter to Health Care Providers: Safe Use of Surgical Staplers and Staples.

US Food and Drug Administration; FDA.

Web Resource

Government Resource

Maalox Total Relief and Maalox Liquid Products: Medication Use Errors.

US Food and Drug Administration; FDA.

Web Resource

Government Resource

Important change to heparin container labels to clearly state the total drug strength.

US Food and Drug Administration; FDA.

Web Resource

Government Resource

Serious medication errors from intravenous administration of nimodipine oral capsules.

United States Food and Drug Administration; FDA.